Devote brand-new high-speed vial filling line for production of Moderna’s Covid-19 vaccine
Vaccine maker Moderna and Catalent, a shipment innovation supplier, have actually broadened their tactical partnership to devote a brand-new vial filling line for the manufacture of Moderna’s Covid-19 vaccine, and perhaps other investigational medical programs in the works, at Catalent’s biologics center in Bloomington, IN.
In June 2020, Catalent and Moderna stated that Catalent would supply aseptic vial filling and product packaging from its Bloomington website, together with extra staffing needed for ongoing manufacturing production of a preliminary 100 million dosages of Moderna’s vaccine, an objective that was achieved in March.
As part of this broadened contract, Catalent will now commit to Moderna’s usage a brand-new high-speed filling line at this website through June 2023. Catalent will likewise be offering examination, labeling, cartoning and last product packaging for these programs.